beatandraise : Equity Research with AI and ChatGPT on SEC Edgar

beatandraise.com

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue	$ 117,929	$ 85,965	$ 70,697
Costs and expenses:
Cost of revenue	22,649	16,692	12,770
Research and development	24,655	18,447	13,600
Marketing and sales	14,043	11,591	9,876
General and administrative	9,829	6,564	10,465
Total costs and expenses	71,176	53,294	46,711
Income from operations	46,753	32,671	23,986
Interest and other income, net	531	509	826
Income before provision for income taxes	47,284	33,180	24,812
Provision for income taxes	7,914	4,034	6,327
Net income	$ 39,370	$ 29,146	$ 18,485
Earnings per share attributable to Class A and Class B common stockholders:
Basic (in dollars per share)	$ 13.99	$ 10.22	$ 6.48
Diluted (in dollars per share)	$ 13.77	$ 10.09	$ 6.43
Weighted-average shares used to compute earnings per share attributable to Class A and Class B common stockholders:
Basic (in shares)	2,815	2,851	2,854
Diluted (in shares)	2,859	2,888	2,876
Share-based compensation expense included in costs and expenses:
Share-based compensation expense included in costs and expenses	$ 9,164	$ 6,536	$ 4,836
Cost of revenue
Share-based compensation expense included in costs and expenses:
Share-based compensation expense included in costs and expenses	577	447	377
Research and development
Share-based compensation expense included in costs and expenses:
Share-based compensation expense included in costs and expenses	7,106	4,918	3,488
Marketing and sales
Share-based compensation expense included in costs and expenses:
Share-based compensation expense included in costs and expenses	837	691	569
General and administrative
Share-based compensation expense included in costs and expenses:
Share-based compensation expense included in costs and expenses	$ 644	$ 480	$ 402

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net income	$ 39,370	$ 29,146	$ 18,485
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	7,967	6,862	5,741
Share-based compensation	9,164	6,536	4,836
Deferred income taxes	609	(1,192)	(37)
Other	(127)	118	39
Changes in assets and liabilities:
Accounts receivable	(3,110)	(1,512)	(1,961)
Prepaid expenses and other current assets	(1,750)	135	47
Other assets	(349)	(34)	41
Accounts payable	1,436	(17)	113
Partners payable	(12)	178	348
Accrued expenses and other current liabilities	3,357	(1,054)	7,300
Deferred revenue and deposits	187	108	123
Other liabilities	941	(527)	1,239
Net cash provided by operating activities	57,683	38,747	36,314
Cash flows from investing activities
Purchases of property and equipment	(18,567)	(15,115)	(15,102)
Purchases of marketable securities	(30,407)	(33,930)	(23,910)
Sales of marketable securities	31,671	11,787	9,565
Maturities of marketable securities	10,915	13,984	10,152
Purchases of equity investments	(47)	(6,361)	(61)
Acquisitions of businesses, net of cash acquired, and purchases of intangible assets	(851)	(388)	(508)
Other investing activities	(284)	(36)	0
Net cash used in investing activities	(7,570)	(30,059)	(19,864)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(5,515)	(3,564)	(2,337)
Repurchases of Class A common stock	(44,537)	(6,272)	(4,202)
Principal payments on finance leases	(677)	(604)	(552)
Net change in overdraft in cash pooling entities	14	24	(223)
Other financing activities	(13)	124	15
Net cash used in financing activities	(50,728)	(10,292)	(7,299)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(474)	279	4
Net increase (decrease) in cash, cash equivalents, and restricted cash	(1,089)	(1,325)	9,155
Cash, cash equivalents, and restricted cash at beginning of the period	17,954	19,279	10,124
Cash, cash equivalents, and restricted cash at end of the period	16,865	17,954	19,279
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents	16,601	17,576	19,079
Total cash, cash equivalents, and restricted cash	16,865	17,954	19,279
Supplemental cash flow data
Cash paid for income taxes, net	8,525	4,229	5,182
Non-cash investing and financing activities:
Property and equipment in accounts payable and accrued expenses and other current liabilities	3,404	2,201	1,887
Acquisition of businesses in accrued expenses and other current liabilities and other liabilities	73	118	0
Other current assets through financing arrangement in accrued expenses and other current liabilities	508	0	0
Repurchases of Class A common stock in accrued expenses and other current liabilities	340	68	43
Prepaid Expenses and Other Current Assets
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Restricted cash	149	241	8
Other Assets
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Restricted cash	$ 115	$ 137	$ 192

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 16,601	$ 17,576
Marketable securities	31,397	44,378
Accounts receivable, net	14,039	11,335
Prepaid expenses and other current assets	4,629	2,381
Total current assets	66,666	75,670
Equity investments	6,775	6,234
Property and equipment, net	57,809	45,633
Operating lease right-of-use assets	12,155	9,348
Intangible assets, net	634	623
Goodwill	19,197	19,050
Other assets	2,751	2,758
Total assets	165,987	159,316
Current liabilities:
Accounts payable	4,083	1,331
Partners payable	1,052	1,093
Operating lease liabilities, current	1,127	1,023
Accrued expenses and other current liabilities	14,312	11,152
Deferred revenue and deposits	561	382
Total current liabilities	21,135	14,981
Operating lease liabilities, non-current	12,746	9,631
Other liabilities	7,227	6,414
Total liabilities	41,108	31,026
Commitments and contingencies
Stockholders' equity:
Common stock, $0.000006 par value; 5,000 million Class A shares authorized, 2,328 million and 2,406 million shares issued and outstanding, as of December 31, 2021 and 2020, respectively; 4,141 million Class B shares authorized, 413 million and 443 million shares issued and outstanding, as of December 31, 2021 and 2020, respectively	0	0
Additional paid-in capital	55,811	50,018
Accumulated other comprehensive income (loss)	(693)	927
Retained earnings	69,761	77,345
Total stockholders' equity	124,879	128,290
Total liabilities and stockholders' equity	$ 165,987	$ 159,316